Literature DB >> 11142034

Neuropathology of fetal nigra transplants for Parkinson's disease.

J H Kordower1, C E Sortwell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142034     DOI: 10.1016/s0079-6123(00)27016-7

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  5 in total

1.  Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Authors:  Sara E Gombash; Jack W Lipton; Timothy J Collier; Lalitha Madhavan; Kathy Steece-Collier; Allyson Cole-Strauss; Brian T Terpstra; Anne L Spieles-Engemann; Brian F Daley; Susan L Wohlgenant; Valerie B Thompson; Fredric P Manfredsson; Ronald J Mandel; Caryl E Sortwell
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  The promise of stem cells in Parkinson disease.

Authors:  J William Langston
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

3.  Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.

Authors:  Krystof S Bankiewicz; Marcel Daadi; Philip Pivirotto; John Bringas; Laura Sanftner; Janet Cunningham; John R Forsayeth; Jamie L Eberling
Journal:  Exp Neurol       Date:  2005-12-09       Impact factor: 5.330

Review 4.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

Review 5.  Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?

Authors:  Philip C Buttery; Roger A Barker
Journal:  Neurotherapeutics       Date:  2020-10-30       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.